Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2023 Earnings Call Transcript

Page 3 of 3

Dalen Meeter : Hey Jake, this is Dalen. I’ll maybe just add one thing. In the savings estimates that we talked about in the prepared remarks and the statement about extending our runway out to the end of 2026, we are contemplating internally some just kind of modest investment for some of the infrastructure that we think will need to stand up to support the good market strategy such as services, right? So, we are contemplating some reinvestment to get this product to market.

Jake Allen: Got it. Thank you. That’s it for me.

Operator: Thank you. That concludes our Q&A session. I’ll now hand the conference back to our host for closing remarks. Please go ahead.

Drew Spaventa: Thank you everyone for joining the call today. I look forward is update you on our progress as we progress this year.

Operator: Thank you everyone. This concludes today’s event. You may disconnect at this time and have a wonderful day. Thank you for your participation.

Follow Singular Genomics Systems Inc.

Page 3 of 3